Drug Patent Expirations for Dec 8, 2016

DrugPatentWatch is your source business intelligence on small-molecule drugs and the 100,000 global patents covering them

Click the patents below for more details, or visit DrugPatentWatch.com for more options.

STRIVERDI RESPIMAT (olodaterol hydrochloride)
Boehringer Ingelheim
Patent number: 6,453,795
Expiration Date: Dec 5, 2016

SPIRIVA RESPIMAT (tiotropium bromide)
Boehringer Ingelheim
Patent number: 6,453,795
Expiration Date: Dec 5, 2016

COMBIVENT RESPIMAT (albuterol sulfate; ipratropium bromide)
Boehringer Ingelheim
Patent number: 6,453,795
Expiration Date: Dec 5, 2016

STIOLTO RESPIMAT (olodaterol hydrochloride; tiotropium bromide)
Boehringer Ingelheim
Patent number: 6,453,795
Expiration Date: Dec 5, 2016

AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER (moxifloxacin hydrochloride)
Bayer Hlthcare
Patent number: 5,849,752
Expiration Date: Dec 5, 2016

AVELOX (moxifloxacin hydrochloride)
Bayer Hlthcare
Patent number: 5,849,752
Expiration Date: Dec 5, 2016

SUMAVEL DOSEPRO (sumatriptan succinate)
Endo Ventures Ltd
Patent number: 6,251,091
Expiration Date: Dec 9, 2016

PLENAXIS (abarelix)
Speciality European
Patent number: 6,180,608
Expiration Date: Dec 11, 2016

PLENAXIS (abarelix)
Speciality European
Patent number: 5,968,895
Expiration Date: Dec 11, 2016

PLENAXIS (abarelix)
Speciality European
Patent number: 6,699,833
Expiration Date: Dec 11, 2016

DrugPatentWatch provides instant access to actionable insights on pharmaceutical drugs.

For more information try a trial

Click here for reuse options!
Copyright 2016 Biotechblog

Leave a Reply

%d bloggers like this: